Medical management of pancreatic neuroendocrine tumors in patients with MEN 1: case report

被引:0
作者
Mohammad Reza Mohajeri-Tehrani
Mahbube Ebrahimpur
Siavosh Nasseri-Moghaddam
Seyed-Mohammad Tavangar
Mahnaz Pejman Sani
Abdollah Zandi
Mohammad Behgam Shadmehr
机构
[1] Tehran University of Medical Sciences,Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute
[2] Tehran University of Medical Sciences,Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute
[3] Tehran University of Medical Sciences,Digestive Disease Research Center, Shariati Hospital
[4] Tehran Medical University of Medical Sciences,Department of Pathology
[5] Atiyeh Hospital,Fellowship of bariatric surgery
[6] Shahid Beheshti University of Medical Sciences,Tracheal Diseases Research Center (TDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD)
来源
Journal of Diabetes & Metabolic Disorders | 2022年 / 21卷
关键词
Multiple endocrine neoplasia; Neuroendocrine tumors; Case management; Octreotide;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2009 / 2011
页数:2
相关论文
共 16 条
[1]  
Thakker RV(2010)Multiple endocrine neoplasia type 1 (MEN1) Best Pract Res Clin Endocrinol Metab 24 355-370
[2]  
Sato Y(2016)Management of gastric and duodenal neuroendocrine tumors World J Gastroenterol 22 6817-6828
[3]  
Grozinsky-Glasberg S(2008)The role of somatostatin analogues in the treatment of neuroendocrine tumours Mol Cell Endocrinol 286 238-250
[4]  
Grossman AB(2012)Multiple endocrine neoplasia type 1 Duodecim 128 2345-2354
[5]  
Korbonits M(2012)Pituitary tumors in patients with MEN1 syndrome Clinics (Sao Paulo) 67 43-48
[6]  
Salmela PI(2016)Clinical utility of lanreotide autogel(R) in gastroenteropancreatic neuroendocrine tumors Drug Des Devel Ther 10 3459-3470
[7]  
Syro LV(1998)Endosonography of the adrenal glands: normal size—pathological findings Exp Clin Endocrinol Diabetes 106 123-129
[8]  
Paragliola RM(1990)Diagnosis of islet cell tumor by means of endoscopic ultrasonography J Clin Gastroenterol 12 218-221
[9]  
Kann P(2016)Octreotide and lanreotide in gastroenteropancreatic neuroendocrine tumors Curr Oncol Rep 18 7-104
[10]  
Taylor KJ(1998)Octreotide: a clinical update Saudi J Gastroenterol 4 147-undefined